BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28343910)

  • 1. Anti-skin-aging effect of epigallocatechin gallate by regulating epidermal growth factor receptor pathway on aging mouse model induced by d-Galactose.
    Chen J; Li Y; Zhu Q; Li T; Lu H; Wei N; Huang Y; Shi R; Ma X; Wang X; Sheng J
    Mech Ageing Dev; 2017 Jun; 164():1-7. PubMed ID: 28343910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
    Adachi S; Nagao T; Ingolfsson HI; Maxfield FR; Andersen OS; Kopelovich L; Weinstein IB
    Cancer Res; 2007 Jul; 67(13):6493-501. PubMed ID: 17616711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin-3-gallate prevents heat shock-induced MMP-1 expression by inhibiting AP-1 activity in human dermal fibroblasts.
    Kim JE; Shin MH; Chung JH
    Arch Dermatol Res; 2013 Sep; 305(7):595-602. PubMed ID: 23912478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs].
    He M; Liu MY; Wang S; Tang QS; Yao WF; Zhao HS; Wei MJ
    Zhong Yao Cai; 2012 Oct; 35(10):1641-4. PubMed ID: 23627134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-Galactose High-Dose Administration Failed to Induce Accelerated Aging Changes in Neurogenesis, Anxiety, and Spatial Memory on Young Male Wistar Rats.
    Cardoso A; Magano S; Marrana F; Andrade JP
    Rejuvenation Res; 2015 Dec; 18(6):497-507. PubMed ID: 25936362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate promotes angiogenesis via up-regulation of Nfr2 signaling pathway in a mouse model of ischemic stroke.
    Bai Q; Lyu Z; Yang X; Pan Z; Lou J; Dong T
    Behav Brain Res; 2017 Mar; 321():79-86. PubMed ID: 28042007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin-3-gallate alleviates galactose-induced aging impairment
    Luo YP; Tang XF; Zhang YC; Chen SM; Wu Q; Li WJ
    Food Funct; 2022 Oct; 13(21):11200-11209. PubMed ID: 36218221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway.
    Ma YC; Li C; Gao F; Xu Y; Jiang ZB; Liu JX; Jin LY
    Oncol Rep; 2014 Mar; 31(3):1343-9. PubMed ID: 24366444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorogenic acid combined with epigallocatechin-3-gallate mitigates D-galactose-induced gut aging in mice.
    Wei R; Su Z; Mackenzie GG
    Food Funct; 2023 Mar; 14(6):2684-2697. PubMed ID: 36752162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.
    Masuda M; Suzui M; Weinstein IB
    Clin Cancer Res; 2001 Dec; 7(12):4220-9. PubMed ID: 11751523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
    Xu H; Becker CM; Lui WT; Chu CY; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wai Man GC; Wang CC
    Fertil Steril; 2011 Oct; 96(4):1021-8. PubMed ID: 21821246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea catechins decrease oxidative stress in surgical menopause-induced overactive bladder in a rat model.
    Juan YS; Chuang SM; Lee YL; Long CY; Wu TH; Chang WC; Levin RM; Liu KM; Huang CH
    BJU Int; 2012 Sep; 110(6 Pt B):E236-44. PubMed ID: 22639915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of a green tea polyphenol, epigallocatechin-3-gallate, against sevoflurane-induced neuronal apoptosis involve regulation of CREB/BDNF/TrkB and PI3K/Akt/mTOR signalling pathways in neonatal mice.
    Ding ML; Ma H; Man YG; Lv HY
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1396-1405. PubMed ID: 28679060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
    Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
    Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells.
    Adachi S; Shimizu M; Shirakami Y; Yamauchi J; Natsume H; Matsushima-Nishiwaki R; To S; Weinstein IB; Moriwaki H; Kozawa O
    Carcinogenesis; 2009 Sep; 30(9):1544-52. PubMed ID: 19578043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
    Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
    Bigelow RL; Cardelli JA
    Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
    Farabegoli F; Govoni M; Spisni E; Papi A
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.